EMBO announces that 67 researchers have been elected to its membership. Through this lifelong honour, new EMBO Members and Associate Members are recognised for their outstanding achievements in the life sciences.
Three new EMBO members have been elected from Oxford:
- Dr Ivan Ahel (Sir William Dunn School of Pathology) studies pathways and protein functions underlying genome stability, which are regulated by a type of protein and DNA modification called ADP-ribosylation.
- Professor Adrian Hill (Jenner Institute) leads research into vaccines for malaria and other major diseases such as COVID-19 and cancer.
- Professor Yang Shi (Ludwig Institute for Cancer Research) is recognised by EMBO for his significant contributions to epigenetic research, which explores how chemical modifications made to chromatin influence the organisation and expression of the human genome.
EMBO has in its membership 1,900 eminent scientists elected by their peers to promote excellence in the life sciences in Europe and beyond. Altogether, 90 Nobel laureates have been members of the organisation since it was established in 1964. Ahel, Hill and Shi are three of 58 new members elected to the organisation this year, along with nine associate members working in seven countries outside Europe.
The new EMBO Members and Associate Members are exceptional scientists, who carry out leading research across a variety of fields, ranging from cell biology and cancer to vaccine development and machine learning. I am delighted to welcome them to EMBO, and I know that they will enrich the life of the organization immensely. - EMBO Director Fiona Watt
EMBO will formally welcome the new members at the annual Members’ Meeting in Heidelberg between 26 and 28 October 2022.